David A Walsh Selected Research

David A Walsh Research Topics

Disease

50	Pain (Aches) 04/2024 - 10/2010
20	Osteoarthritis 04/2024 - 10/2010
15	Inflammation (Inflammations) 11/2022 - 07/2003
10	Synovitis 11/2022 - 04/2004
9	Knee Osteoarthritis 11/2023 - 01/2013
8	Rheumatoid Arthritis 01/2023 - 07/2010
8	Chronic Pain 03/2022 - 01/2016
5	Arthritis (Polyarthritis) 01/2019 - 08/2006
3	Low Back Pain (Lumbago) 12/2023 - 12/2015
2	Drug-Related Side Effects and Adverse Reactions 02/2024 - 05/2013
2	Fatigue 11/2022 - 06/2021
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2018
2	Arthralgia (Joint Pain) 01/2020 - 01/2016
2	Osteophyte 11/2018 - 08/2014
2	Neurogenic Inflammation 11/2015 - 07/2003
1	Cognitive Dysfunction 02/2024
1	Frailty 02/2024
1	Dementia (Dementias) 01/2023
1	Hypersensitivity (Allergy) 11/2021
1	Migraine Disorders (Migraine) 01/2019
1	Necrosis 10/2017
1	Sciatica (Sciatic Neuralgia) 10/2017
1	Hyperalgesia 01/2017

Drug/Important Bio-Agent (IBA)

13	Analgesics (Analgesic Drugs)IBA 11/2023 - 01/2013
7	Iodoacetic AcidIBA 11/2021 - 08/2014
6	CytokinesIBA 07/2023 - 10/2012
6	Nerve Growth Factor (NGF)IBA 01/2019 - 10/2010
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2023 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2019
4	Phosphotransferases (Kinase)IBA 01/2020 - 12/2015
4	TropomyosinIBA 01/2020 - 12/2015
3	Pain-FreeIBA 01/2023 - 03/2019
3	Messenger RNA (mRNA)IBA 01/2017 - 04/2004
3	CarrageenanIBA 01/2016 - 04/2004
3	Substance PIBA 06/2012 - 07/2003
2	14,15-dihydroxyeicosatrienoic acidIBA 04/2024 - 01/2022
2	OxylipinsIBA 04/2024 - 11/2022
2	ametantrone (HAQ)IBA 11/2022 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 11/2022 - 01/2020
2	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2021
2	Capsaicin (Zostrix)FDA Link 01/2021 - 06/2012
2	Cathepsin KIBA 11/2018 - 08/2015
2	Diphosphonates (Bisphosphonates)IBA 08/2014 - 01/2011
2	Antirheumatic Agents (DMARD)IBA 05/2013 - 07/2010
2	PPI 2458IBA 09/2011 - 07/2010
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 04/2004 - 07/2003
1	Arachidonic Acid (Vitamin F)IBA 04/2024
1	AcidsIBA 04/2024
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 04/2024
1	anandamide (arachidonylethanolamide)IBA 04/2024
1	8,9-epoxyeicosatrienoic acidIBA 04/2024
1	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 04/2024
1	ORALIT (ORS)IBA 10/2023
1	Cystine (L-Cystine)IBA 07/2023
1	Cortisone FDA Link 07/2023
1	Dihydroxyphenylalanine (Dopa)IBA 07/2023
1	OrnithineIBA 07/2023
1	glycolithocholic acidIBA 07/2023
1	Amino Acids FDA Link 07/2023
1	CholesterolIBA 07/2023
1	Succinic Acid (Succinate)IBA 07/2023
1	CarnosineIBA 07/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2023
1	Inflammation MediatorsIBA 11/2022
1	LipidsIBA 11/2022
1	Epoxide HydrolasesIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	Serine (L-Serine)FDA Link 11/2021
1	EndorphinsIBA 11/2021
1	Naloxone (Narcan)FDA LinkGeneric 11/2021
1	Morphine (MS Contin)FDA LinkGeneric 11/2021
1	LigandsIBA 11/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2021
1	tanezumabIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 03/2019
1	mRNA Cleavage and Polyadenylation FactorsIBA 01/2019
1	2'-deoxyadenosineIBA 01/2019
1	cordycepinIBA 01/2019
1	Tartrate-Resistant Acid PhosphataseIBA 01/2019
1	amsonic acid (DAS)IBA 12/2018
1	CRA 013783IBA 11/2018
1	Adalimumab (Humira)FDA Link 10/2017
1	AntibodiesIBA 10/2017
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017

Therapy/Procedure

6	Pain Management 02/2024 - 01/2015
6	Therapeutics 07/2023 - 01/2014
5	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2022 - 11/2014
5	Replacement Arthroplasty 01/2022 - 12/2012
5	Intra-Articular Injections 01/2020 - 07/2010
3	Injections 10/2017 - 12/2015
2	Analgesia 11/2021 - 09/2017
2	Biological Therapy 10/2017 - 12/2012
1	Polypharmacy 02/2024
1	Precision Medicine 01/2023
1	Aftercare (After-Treatment) 01/2019
1	Activities of Daily Living (ADL) 01/2019
1	Subcutaneous Injections 10/2017
1	Conservative Treatment 01/2017